Biblio
“Blood Pressure and Hispanic/Latino Cognitive Function: Hispanic Community Health Study/Study of Latinos Results.”, J Alzheimers Dis, vol. 59, no. 1, pp. 31-42, 2017.
, “Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1103-1117, 2022.
, “Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.”, J Alzheimers Dis, 2015.
, “A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?”, J Alzheimers Dis, vol. 90, no. 3, pp. 963-966, 2022.
, “A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.”, J Alzheimers Dis, vol. 64, no. s1, pp. S289-S297, 2018.
, “Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance.”, J Alzheimers Dis, vol. 90, no. 3, pp. 967-974, 2022.
, “A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, 2015.
, “Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.”, J Alzheimers Dis, vol. 79, no. 1, pp. 177-195, 2021.
, “Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.”, J Alzheimers Dis, vol. 52, no. 2, pp. 561-72, 2016.
, “Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1407-1419, 2024.
, “Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 23-35, 2017.
, “Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.”, J Alzheimers Dis, vol. 50, no. 1, pp. 249-60, 2016.
, “Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer's Disease Rat Model.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1197-1211, 2017.
, “Body Mass Index and Mild Cognitive Impairment Among Middle-Aged and Older Adults from Low- and Middle-Income Countries.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1095-1105, 2021.
, “Body Mass Index and Mortality Rate in Korean Patients with Alzheimer's Disease.”, J Alzheimers Dis, 2015.
, “Body Mass Index, Height, and Socioeconomic Position in Adolescence, Their Trajectories into Adulthood, and Cognitive Function in Midlife.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1207-1221, 2017.
, “Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 563-585, 2018.
, “Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues.”, J Alzheimers Dis, vol. 85, no. 2, pp. 889-903, 2021.
, “Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 74, no. 1, pp. 189-197, 2020.
, “Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy?”, J Alzheimers Dis, vol. 64, no. s1, pp. S397-S404, 2018.
, “Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset.”, J Alzheimers Dis, vol. 66, no. 1, pp. 229-237, 2018.
, “Brain Amyloid-β Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1089-99, 2016.
, “Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1101-9, 2016.
, “Brain Biomarkers in Familial Alzheimer's Disease Mouse Models.”, J Alzheimers Dis, vol. 60, no. 3, pp. 949-958, 2017.
, “Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S313-S327, 2018.
,